Episode 37: David Bearss, Ph.D. - President And CEO Of Halia Therapeutics First In Human By Vial podcast

Artwork

Science Biology Vial

Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

First In Human By Vial « »
Episode 37: David Bearss, Ph.D. - President and CEO of Halia Therapeutics

1+ y ago 20:23

Del

MP3•Episode hjem

Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

For episode 37, we connect with David Bearss, President and CEO of Halia Therapeutics. Learn more about the connection between chronic inflammation and disease, and how Halia is using their novel therapies to treat both inflammatory disorders and neurological diseases.

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.

Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials

… continue reading

62 episoder

#Science #Biology #Vial

Artwork

Episode 37: David Bearss, Ph.D. - President and CEO of Halia Therapeutics

First In Human By Vial

published 1+ y ago

Del

MP3•Episode hjem

Indhold leveret af Vial. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Vial eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

For episode 37, we connect with David Bearss, President and CEO of Halia Therapeutics. Learn more about the connection between chronic inflammation and disease, and how Halia is using their novel therapies to treat both inflammatory disorders and neurological diseases.

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.

Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials

… continue reading

62 episoder

#Science #Biology #Vial

Semua episod

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner